CNS Inflammation and Bone Marrow Neuropathy in Type 1 Diabetes

By using pseudorabies virus expressing green fluorescence protein, we found that efferent bone marrow–neural connections trace to sympathetic centers of the central nervous system in normal mice. However, this was markedly reduced in type 1 diabetes, suggesting a significant loss of bone marrow inne...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of pathology Vol. 183; no. 5; pp. 1608 - 1620
Main Authors Hu, Ping, Thinschmidt, Jeffrey S., Yan, Yuanqing, Hazra, Sugata, Bhatwadekar, Ashay, Caballero, Sergio, Salazar, Tatiana, Miyan, Jaleel A., Li, Wencheng, Derbenev, Andrei, Zsombok, Andrea, Tikhonenko, Maria, Dominguez, James M., McGorray, Susan P., Saban, Daniel R., Boulton, Michael E., Busik, Julia V., Raizada, Mohan K., Chan-Ling, Tailoi, Grant, Maria B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2013
American Society for Investigative Pathology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:By using pseudorabies virus expressing green fluorescence protein, we found that efferent bone marrow–neural connections trace to sympathetic centers of the central nervous system in normal mice. However, this was markedly reduced in type 1 diabetes, suggesting a significant loss of bone marrow innervation. This loss of innervation was associated with a change in hematopoiesis toward generation of more monocytes and an altered diurnal release of monocytes in rodents and patients with type 1 diabetes. In the hypothalamus and granular insular cortex of mice with type 1 diabetes, bone marrow–derived microglia/macrophages were activated and found at a greater density than in controls. Infiltration of CD45+/CCR2+/GR-1+/Iba-1+ bone marrow–derived monocytes into the hypothalamus could be mitigated by treatment with minocycline, an anti-inflammatory agent capable of crossing the blood-brain barrier. Our studies suggest that targeting central inflammation may facilitate management of microvascular complications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9440
1525-2191
1525-2191
DOI:10.1016/j.ajpath.2013.07.009